JUL 22, 2021 12:00 PM EDT

Genetic engineering approaches to support clinical applications of T-cell receptor libraries targeting oncogenic mutations

C.E. Credits: Florida CE P.A.C.E. CE
Speaker

Abstract

T-cells targeting shared oncogenic mutations can induce durable tumor regression in epithelial cancer patients. Such T cells can be detected in tumor-infiltrating lymphocytes and peripheral blood of patients with the common metastatic epithelial cancers. In recent years, we and others have worked toward developing libraries of T-cell receptors targeting oncogenic mutations such as KRAS and TP53. Such T-cell receptor libraries offer an opportunity to treat patients with autologous or allogeneic T-cells genetically engineered to express selected T-cell receptors. Although attractive, such clinical application of T-cell receptor libraries should be accompanied by innovative genetic engineering platforms allowing cheaper, faster, and more flexible manufacturing solutions. This talk will discuss the methods to isolate, clone, and validate T-cell receptors targeting oncogenic mutations, the therapeutic potential of such libraries, and the genetic engineering platforms currently used for clinical manufacturing. We will also address the genetic engineering tools needed to allow such an approach to become widely and commercially applicable.

Learning Objectives:

1. Discuss methods to isolate, clone, and validate T-cell receptors targeting oncogenic mutations.

2. Define the therapeutic potential of TCR libraries targeting oncogenic mutations.

3. Indicate the current and future genetic engineering platforms needed to support clinical applications using off-the-shelf TCR libraries.


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
JUN 24, 2021 8:00 AM PDT
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
APR 20, 2021 4:30 PM PDT
C.E. CREDITS
APR 20, 2021 4:30 PM PDT
COVID-19 is a severe disease that has caused >1 million deaths in under one year. As this disease is novel, the molecular and cellular underpinnings of the progressive tissue injury are p...
Loading Comments...
Show Resources